Steatocystoma multiplex: those little tumours. by de Moll, Ellen H. et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Dermatology and Cutaneous
Biology Faculty Papers
Department of Dermatology and Cutaneous
Biology
9-1-2014
Steatocystoma multiplex: those little tumours.
Ellen H. de Moll
University of Connecticut
W. Clark Lambert
Rutgers University - Newark
Lawrence Charles Parish
Thomas Jefferson University, Lawrence.Parish@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/dcbfp
Part of the Dermatology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Dermatology and Cutaneous Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
de Moll, Ellen H.; Lambert, W. Clark; and Parish, Lawrence Charles, "Steatocystoma multiplex:
those little tumours." (2014). Department of Dermatology and Cutaneous Biology Faculty Papers. Paper
75.
https://jdc.jefferson.edu/dcbfp/75
1 
 
 
Editorial 
 
Steatocystoma Multiplex: Those little tumours 
Ellen H. de Moll, BA, W. Clark Lambert, MD, PhD, Lawrence Charles Parish, MD, 
MD (Hon) 
 
 
 
From the University of Connecticut  School of Medicine, Farmington, CT, the 
Department of Dermatology, New Jersey Medical School, Rutgers University, 
Newark, NJ,  and the Department of Dermatology and Cutaneous Biology, 
Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 
 
 
 
 
 
 
 
 
Corresponding author: Lawrence Charles Parish, MD, MD (Hon), 1845 Walnut 
Street Suite 1650, Philadelphia, PA 19103; tel: 215.563.8333 
 
  
2 
EDITORIAL 
 
 
Hardly a clinician in the twenty-first century would have difficulty in identifying 
steatocystoma multiplex (SM). The characteristic asymptomatic yellow or skin-colored 
dermal papules, typically found on the trunk, upper aspects of the arms, scrotum, or 
chest (Figure 1) are difficult to miss, particularly when a young woman is concerned 
about her appearance with a low-cut blouse (Figure 2) or when a young man thinks his 
acne as gone astray. 
 
DEVELOPING A CONCEPT 
The first descriptions of these “innumerable number of prominent little tumours” 
that varied in size from “a millet-seed to a large pea” were made by James Pringle 
(1855-1922), better known for having delineated the adenoma sebaceum of tuberous 
sclerosis.1 In 1899, he presented to the Dermatological Society of London the case of a 
21-year-old man with asymptomatic “lumps” that had appeared over the previous five 
years.1 Puncture of one of these lesions revealed “abundant fluid like thin skim-milk.”1 
James Galloway (1862-1922) performed the histopathologic examination on a biopsy 
specimen taken from this patient and decided that the lesions were due to “hypertrophy 
of the sebaceous gland, liquefaction of its contents, and retention of its secretion.”1  
In 1898, Pier Lodovico Bosellini (1873-1945), then in Bologna, described a 40-
year old man who was experiencing eight years of asymptomatic “multiple follicular 
cutaneous cysts.”2 He concluded that it was a retention cyst due to keratin plugging of 
the sebaceous glands. In Germany in 1917, Hans Günther (1884-1956), who would later 
distinguish himself with his work on porphyrins, analyzed the biopsy specimen of a 
similar patient, and suggested the term sebocystomatosis, implying the pathologic 
process to be analogous to lipomatosis.i   
In 1933. Isaac Muende (1901-1987) and  Archibald Cathcart Roxburgh (1886-
1954) in London claimed that Pringle’s nomenclature had priority to Günther’s.  Their 
description of SM is quite detailed: 
“It was an affection of the hair follicle, just above the entrance of the 
gland, which prevented sebum from reaching the surface. The sebum 
was produced and dilated the lower part of the hair follicle, the remnants 
of the sebaceous gland being squeezed to one side. In the end, when it 
reached a certain size- that of a pea- it ceased to function.”3 
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The term sebocystomatosis continued to be used through the 1950’s, as shown 
by a paper in the British Journal of Dermatology and Syphilis, that described the papules 
as “gelatin capsules,” and defined sebocystomatosis as “a distinct clinical entity, 
characterized by the occurrence on various parts of the body of small cystic tumors 
involving the sebaceous apparatus without causing any change in the overlying skin.”4 
An additional term was hereditary epidermal polycystic disease.5  
  
CURRENT CONCEPTS 
Today, SM is recognized as a benign nevoid malformation of the pilosebaceous 
apparatus that shows a mixture of keratinizing epithelium and sebaceous lobules 
attached to the epidermis by a thin epidermal strand.6 A subtype of SM, known as 
steatocystoma multiplex suppurativa (SMS), presents with inflamed lesions that can 
rupture and scar.6 On histology, SM appears as epithelial-lined sebum-filled dermal 
cysts, approximately 3-10 millimeters in size, with sebaceous glands present in the cyst 
wall (Figure 3). On the luminal side of the cyst wall is an eosinophilic cuticle with keratin, 
oil, and hairs in the lumen.7  A single lesion may also occur; this entity is designated 
“steatocystoma simplex (SS)”.  In either SM or SS, the sebaceous gland tissue may be 
prominent or quite subtle (Figure 4).  
SM can occur sporadically in an autosomal dominant pattern or as part of a 
syndrome, including Alagille syndrome (autosomal dominant microdeletion of the JAG1 
gene on chromosome 20p causing gastrointestinal, cardiovascular, and facial defects)7,8 
SM has also been observed in association with pachyonychia congenita type II.6 
Mutations of the keratin 17 (K17) gene have been reported in familial cases of SM, 
although the exact origin of the spontaneous form is not fully understood. The burden of 
disease can vary from a handful of small cysts to more extensive disease with larger 
cysts. Cysts typically appear during adolescence and early adulthood, indicating a 
potential link to hormonal effect, and persist throughout adulthood. The classic 
differential diagnosis  includes epidermal inclusion cysts, milia, trichilemmal cysts, and 
eruptive vellus hair cysts (EVHC). 
Although earlier concepts placed the disease as predominantly afflicting men of 
Northern European descent between the ages of 19 and 28,4 current thought has no 
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gender distinction or national preference.   Today, the disease is recognized as having a 
roughly equal gender distribution, with an average age of onset of 26 years old.9  
Treatment of SM remains unsatisfactory: cryosurgery, aspiration, excision, 
incision, lasersurgery, with each having its proponents.  Oral retinoids and tetracycline 
have been tried with minimal success.  Similarly, intralesional steroids  have some 
advocates.7  
 
CONCLUSIONS 
What may seem merely a nuisance to some is quite bothersome to others.  While 
SM is easily recognized, treatment options are not rewarding.  The question remains 
how can we rid our patients of “these gelatinous capsules?”  
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Figures 
Figure 1: Steatocystoma multiplex.  Multiple lesions on the trunk of a young man. 
Figure 2: Steatocystoma multiplex.  Lesions on the breasts of a young woman. 
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Figure 3: Steatocystoma multiplex.  Photomicrograph showing diagnostic feature 
of sebaceous gland tissue within the epithelium of a cyst.  Steatocystoma 
simplex shows similar histology.  Hematoxylin and eosin, X 710. 
Figure 4: Steatocystoma multiplex.  Photomicrograph showing diagnostic 
features of sebaceous gland tissue within the epithelium of a cyst.  Only a tiny 
fragment of sebaceous gland tissue is seen. Steatocystoma simplex may show 
similar histology.  Hematoxylin and eosin, X 710 
 
                                                        
i Günther’s paper was originally submitted in 1914, however, it could only be 
printed after World War I. 
